Trial is the first randomized, controlled clinical trial evaluating cannabidiol to treat children and adolescents living with a developmental and epileptic encephalopathy known as Epilepsy with Myoclonic-Atonic Seizures DUBLIN, Aug. 18, 2022 /PRNewswire/ — Jazz Pharmaceuticals plc…